Mangoceuticals
MGRX
MGRX
13 hedge funds and large institutions have $320K invested in Mangoceuticals in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$206K | |
| 2 | +$31K | |
| 3 | +$20.2K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$8.93K |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
+$7.41K |
Top Sellers
| 1 | -$41.2K | |
| 2 | -$30.4K | |
| 3 | -$17K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$16.1K |
| 5 |
Morgan Stanley
New York
|
-$3.15K |